The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer (Q46468957)
Jump to navigation
Jump to search
scientific article published on 18 July 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer |
scientific article published on 18 July 2008 |
Statements
1 reference
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer (English)
1 reference
Louis P Garrison
1 reference
David L Veenstra
1 reference
Josh J Carlson
1 reference
Scott D Ramsey
1 reference
18 July 2008
1 reference
1 reference
12
1 reference
1
1 reference
20-27
1 reference
Identifiers
1 reference